MarkWide Research

Sale!

Liquid Biopsy Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: October, 2022
No of Pages: 159
Delivery Format: PDF+Excel

$2,950.00

Liquid Biopsy Market size exceeded USD 1.2 billion in 2020 and is anticipated to grow at a CAGR of over 29.7% between 2021 and 2027. Growing awareness regarding causes and diagnosis of cancer with several awareness campaigns will contribute to the demand for liquid biopsy in the coming years.

Continuous technological advancements will benefit the liquid biopsy market growth

Increasing preference for non-invasive technologies in disease diagnosis is poised to positively impact the adoption of liquid biopsy. Significant rise in the number of patients suffering from various cancers will create the substantial need for accurate diagnostic methods. Furthermore, growing number of ongoing clinical trials for the development of innovative solutions will accelerate the market expansion. Moreover, several advantages associated with liquid biopsy such as less invasive nature, improved precision and post-treatment monitoring will stimulate the industry demand.
The COVID-19 pandemic has moderately impacted the related product sales due to the disruption in healthcare services. The companies witnessed modest decline in the sales of reagents and kits in some countries. However, continued demand for instruments has reduced the intensity of negative impact. Additionally, with decline in number of COVID-19 cases, the sales of reagents are expected to grow at pre-pandemic pace.

High sensitivity of biomarkers allowing accurate diagnosis and monitoring to strengthen the industry expansion

Circulating tumor DNA segment in the liquid biopsy market valued at USD 550 million in 2020. Well-developed technology providing accuracy in tumor detection has significantly contributed to the industry revenue. High sensitivity in detection of early stage and advanced cancer, specifically breast cancer, will offer growth opportunities to the segment. In addition, the ctDNA biomarkers are used to study tumor progression among patients during clinical studies. Further, ctDNA provides an alternative pathway for the molecular profiling of tumor DNA in biopsy procedures.

Expanding availability with continuous product launches will augment the market value

Kits & reagents segment dominated more than 50% of the market share in 2020 led by the increasing acceptance of liquid biopsy in reference laboratories and research institutes. Several companies are involved in the development of innovative products to enhance the precision in liquid biopsy testing during diagnosis. Further, the integration and practice of liquid biopsy in clinical facilities will boost the product demand in the coming years.

Growing need for non-invasive techniques among patients with metastatic conditions to spur the demand for the liquid biopsy

Lung cancer segment is predicted to showcased 29.7% growth rate through 2027 impelled by the high incidence rate owing to the adoption of unhealthy lifestyle including smoking and tobacco consumption. In addition, the high risk of metastatic conditions among patients with lung cancer will support the acceptance of advanced biomarkers testing. The development of innovative tests specific to targets will further strengthen the segment expansion.

Presence of leading players focusing on continuous development to secure approvals will propel the product demand in North America region

North America liquid biopsy market captured 31% of revenue share in 2020 on account of the availability of advanced products along with the presence of leading industry players. Further, rising incidence of cancer, faster adoption of advanced methods and highly advanced infrastructure will augment the regional growth. Accelerating demand for non-invasive disease diagnosis and continuous product launches with high focus on R&D by the market players will offer unprecedented growth opportunities to the industry.

Product innovations and strategic alliances to broaden market offerings are assisting the industry leaders in business expansion

Major companies operating in the liquid biopsy market are F. Hoffmann-La Roche Ltd., BIOCEPT, Inc., QIAGEN, Myriad Genetics, Inc., Guardant Health, Inc., Illumina, Inc., Lucence health Inc., and EPIGENOMICS AG. These participants are adopting various growth strategies such as collaborations, acquisitions & mergers, partnerships, and product launches to gain competitive edge over others.

The liquid biopsy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027 for the following segments:

Market, By Biomarkers

  • Circulating Tumor Cells (CTC)
  • Circulating Tumor DNA (ctDNA)
  • Others

Market, By Product

  • Kits & Reagents
  • Assay & Reagents
  • Others

Market, By Application

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates & working

1.2.1    North America

1.2.2    Europe

1.2.3    Asia Pacific

1.2.4    Latin America

1.2.5    Middle East and Africa

1.3    Forecast calculations

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1    Paid sources

1.5.1.2    Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Liquid biopsy industry 3600 synopsis, 2016 – 2027 (USD Million)

2.1.1    Business trends

2.1.2    Biomarkers trends

2.1.3    Product trends

2.1.4    Application trends

2.1.5    Regional trends

Chapter 3   Liquid Biopsy Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 – 2027 (USD Million)

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Continuous technological advancements in cancer diagnostics

3.3.1.2    Increasing preference for non-invasive disease diagnosis

3.3.1.3    Growing prevalence of cancer worldwide

3.3.1.4    Rising awareness regarding early disease diagnosis

3.3.2    Industry pitfalls & challenges

3.3.2.1    Stringent regulatory framework

3.3.2.2    Lack of skilled professionals

3.4    Growth potential analysis

3.4.1    By biomarkers

3.4.2    By product

3.4.3    By application

3.5    COVID-19 impact analysis

3.6    Service provider landscape

3.7    Porter’s analysis

3.8    Competitive landscape, 2020

3.9    PESTEL analysis

Chapter 4   Liquid Biopsy Market, By Biomarkers

4.1    Key segment trends

4.2    Circulating tumor cells (CTC)

4.2.1    Market size, by region, 2016 – 2027 (USD Million)

4.3    Circulating tumor DNA (ctDNA)

4.3.1    Market size, by region, 2016 – 2027 (USD Million)

4.4    Others

4.4.1    Market size, by region, 2016 – 2027 (USD Million)

Chapter 5   Liquid Biopsy Market, By Product

5.1    Key segment trends

5.2    Kits & reagents

5.2.1    Market size, by region, 2016 – 2027 (USD Million)

5.3    Assay & panels

5.3.1    Market size, by region, 2016 – 2027 (USD Million)

5.4    Others

5.4.1    Market size, by region, 2016 – 2027 (USD Million)

Chapter 6   Liquid Biopsy Market, By Application

6.1    Key segment trends

6.2    Lung cancer

6.2.1    Market size, by region, 2016 – 2027 (USD Million)

6.3    Breast cancer

6.3.1    Market size, by region, 2016 – 2027 (USD Million)

6.4    Colorectal cancer

6.4.1    Market size, by region, 2016 – 2027 (USD Million)

6.5    Prostate cancer

6.5.1    Market size, by region, 2016 – 2027 (USD Million)

6.6    Others

6.6.1    Market size, by region, 2016 – 2027 (USD Million)

Chapter 7   Liquid Biopsy Market, By Region

7.1    Key regional trends

7.2    North America

7.2.1    Market size by country, 2016 – 2027 (USD Million)

7.2.2    Market size by biomarkers, 2016 – 2027 (USD Million)

7.2.3    Market size by product, 2016 – 2027 (USD Million)

7.2.4    Market size by application, 2016 – 2027 (USD Million)

7.2.5    U.S.

7.2.5.1    Market size by biomarkers, 2016 – 2027 (USD Million)

7.2.5.2    Market size by product, 2016 – 2027 (USD Million)

7.2.5.3    Market size by application, 2016 – 2027 (USD Million)

7.2.6    Canada

7.2.6.1    Market size by biomarkers, 2016 – 2027 (USD Million)

7.2.6.2    Market size by product, 2016 – 2027 (USD Million)

7.2.6.3    Market size by application, 2016 – 2027 (USD Million)

7.3    Europe

7.3.1    Market size by country, 2016 – 2027 (USD Million)

7.3.2    Market size by biomarkers, 2016 – 2027 (USD Million)

7.3.3    Market size by product, 2016 – 2027 (USD Million)

7.3.4    Market size by application, 2016 – 2027 (USD Million)

7.3.5    Germany

7.3.5.1    Market size by biomarkers, 2016 – 2027 (USD Million)

7.3.5.2    Market size by product, 2016 – 2027 (USD Million)

7.3.5.3    Market size by application, 2016 – 2027 (USD Million)

7.3.6    UK

7.3.6.1    Market size by biomarkers, 2016 – 2027 (USD Million)

7.3.6.2    Market size by product, 2016 – 2027 (USD Million)

7.3.6.3    Market size by application, 2016 – 2027 (USD Million)

7.3.7    France

7.3.7.1    Market size by biomarkers, 2016 – 2027 (USD Million)

7.3.7.2    Market size by product, 2016 – 2027 (USD Million)

7.3.7.3    Market size by application, 2016 – 2027 (USD Million)

7.3.8    Italy

7.3.8.1    Market size by biomarkers, 2016 – 2027 (USD Million)

7.3.8.2    Market size by product, 2016 – 2027 (USD Million)

7.3.8.3    Market size by application, 2016 – 2027 (USD Million)

7.3.9    Spain

7.3.9.1    Market size by biomarkers, 2016 – 2027 (USD Million)

7.3.9.2    Market size by product, 2016 – 2027 (USD Million)

7.3.9.3    Market size by application, 2016 – 2027 (USD Million)

7.4    Asia Pacific

7.4.1    Market size by country, 2016 – 2027 (USD Million)

7.4.2    Market size by biomarkers, 2016 – 2027 (USD Million)

7.4.3    Market size by product, 2016 – 2027 (USD Million)

7.4.4    Market size by application, 2016 – 2027 (USD Million)

7.4.5    Japan

7.4.5.1    Market size by biomarkers, 2016 – 2027 (USD Million)

7.4.5.2    Market size by product, 2016 – 2027 (USD Million)

7.4.5.3    Market size by application, 2016 – 2027 (USD Million)

7.4.6    China

7.4.6.1    Market size by biomarkers, 2016 – 2027 (USD Million)

7.4.6.2    Market size by product, 2016 – 2027 (USD Million)

7.4.6.3    Market size by application, 2016 – 2027 (USD Million)

7.4.7    India

7.4.7.1    Market size by biomarkers, 2016 – 2027 (USD Million)

7.4.7.2    Market size by product, 2016 – 2027 (USD Million)

7.4.7.3    Market size by application, 2016 – 2027 (USD Million)

7.5    Latin America

7.5.1    Market size by country, 2016 – 2027 (USD Million)

7.5.2    Market size by biomarkers, 2016 – 2027 (USD Million)

7.5.3    Market size by product, 2016 – 2027 (USD Million)

7.5.4    Market size by application, 2016 – 2027 (USD Million)

7.5.5    Brazil

7.5.5.1    Market size by biomarkers, 2016 – 2027 (USD Million)

7.5.5.2    Market size by product, 2016 – 2027 (USD Million)

7.5.5.3    Market size by application, 2016 – 2027 (USD Million)

7.5.6    Mexico

7.5.6.1    Market size by biomarkers, 2016 – 2027 (USD Million)

7.5.6.2    Market size by product, 2016 – 2027 (USD Million)

7.5.6.3    Market size by application, 2016 – 2027 (USD Million)

7.6    Middle East & Africa

7.6.1    Market size by country, 2016 – 2027 (USD Million)

7.6.2    Market size by biomarkers, 2016 – 2027 (USD Million)

7.6.3    Market size by product, 2016 – 2027 (USD Million)

7.6.4    Market size by application, 2016 – 2027 (USD Million)

7.6.5    South Africa

7.6.5.1    Market size by biomarkers, 2016 – 2027 (USD Million)

7.6.5.2    Market size by product, 2016 – 2027 (USD Million)

7.6.5.3    Market size by application, 2016 – 2027 (USD Million)

7.6.6    Saudi Arabia

7.6.6.1    Market size by biomarkers, 2016 – 2027 (USD Million)

7.6.6.2    Market size by product, 2016 – 2027 (USD Million)

7.6.6.3    Market size by application, 2016 – 2027 (USD Million)

Chapter 8   Company Profiles

8.1    Competitive dashboard, 2020

8.2    QIAGEN

8.2.1    Business overview

8.2.2    Financial data

8.2.3    Product landscape

8.2.4    Strategic outlook

8.2.5    SWOT analysis

8.3    BIOCEPT, Inc.

8.3.1    Business overview

8.3.2    Financial data

8.3.3    Product landscape

8.3.4    Strategic outlook

8.3.5    SWOT analysis

8.4    Myriad Genetics, Inc.

8.4.1    Business overview

8.4.2    Financial data

8.4.3    Product landscape

8.4.4    Strategic outlook

8.4.5    SWOT analysis

8.5    Guardant Health, Inc.

8.5.1    Business overview

8.5.2    Financial data

8.5.3    Product landscape

8.5.4    Strategic outlook

8.5.5    SWOT analysis

8.6    Illumina, Inc.

8.6.1    Business overview

8.6.2    Financial data

8.6.3    Product landscape

8.6.4    Strategic outlook

8.6.5    SWOT analysis

8.7    F. Hoffmann La Roche Ltd.

8.7.1    Business overview

8.7.2    Financial data

8.7.3    Product landscape

8.7.4    Strategic outlook

8.7.5    SWOT analysis

8.8    Thermo Fisher Scientific, Inc.

8.8.1    Business overview

8.8.2    Financial data

8.8.3    Product landscape

8.8.4    Strategic outlook

8.8.5    SWOT analysis

8.9    Angle plc.

8.9.1    Business overview

8.9.2    Financial data

8.9.3    Product landscape

8.9.4    Strategic outlook

8.9.5    SWOT analysis

8.10    Oncimmune

8.10.1    Business overview

8.10.2    Financial data

8.10.3    Product landscape

8.10.4    Strategic outlook

8.10.5    SWOT analysis

8.11    EPIGENOMICS AG

8.11.1    Business overview

8.11.2    Financial data

8.11.3    Product landscape

8.11.4    Strategic outlook

8.11.5    SWOT analysis

8.12    Lucene Health Inc.

8.12.1    Business overview

8.12.2    Financial data

8.12.3    Product landscape

8.12.4    Strategic outlook

8.12.5    SWOT analysis

8.13    Freenome Holdings, Inc.

8.13.1    Business overview

8.13.2    Financial data

8.13.3    Product landscape

8.13.4    Strategic outlook

8.13.5    SWOT analysis

8.14    MDxHealth SA

8.14.1    Business overview

8.14.2    Financial data

8.14.3    Product landscape

8.14.4    Strategic outlook

8.14.5    SWOT analysis

8.15    Bio RAD Laboratories Inc.

8.15.1    Business overview

8.15.2    Financial data

8.15.3    Product landscape

8.15.4    Strategic outlook

8.15.5    SWOT analysis

8.16    Menarini Silicon Biosystems

8.16.1    Business overview

8.16.2    Financial data

8.16.3    Product landscape

8.16.4    Strategic outlook

8.16.5    SWOT analysis

Data Tables

TABLE 1    Global liquid biopsy market, 2016 – 2020 (USD Million)

TABLE 2    Global liquid biopsy market, 2021 – 2027 (USD Million)

TABLE 3    Global liquid biopsy market, by biomarkers, 2016 – 2020 (USD Million)

TABLE 4    Global liquid biopsy market, by biomarkers, 2021 – 2027 (USD Million)

TABLE 5    Global liquid biopsy market, by product, 2016 – 2020 (USD Million)

TABLE 6    Global liquid biopsy market, by product, 2021 – 2027 (USD Million)

TABLE 7    Global liquid biopsy market, by application, 2016 – 2020 (USD Million)

TABLE 8    Global liquid biopsy market, by application, 2021 – 2027 (USD Million)

TABLE 9    Global liquid biopsy market, by region, 2016 – 2020 (USD Million)

TABLE 10    Global liquid biopsy market, by region, 2021 – 2027 (USD Million)

TABLE 11    Industry impact forces

TABLE 12    Circulating tumor cells market size, by region, 2016 – 2020 (USD Million)

TABLE 13    Circulating tumor cells market size, by region, 2021 – 2027 (USD Million)

TABLE 14    Circulating tumor DNA market size, by region, 2016 – 2020 (USD Million)

TABLE 15    Circulating tumor DNA market size, by region, 2021 – 2027 (USD Million)

TABLE 16    Others market size, by region, 2016 – 2020 (USD Million)

TABLE 17    Others market size, by region, 2021 – 2027 (USD Million)

TABLE 18    Kits & reagents market size, by region, 2016 – 2020 (USD Million)

TABLE 19    kits & reagents market size, by region, 2021 – 2027 (USD Million)

TABLE 20    Assay & panels market size, by region, 2016 – 2020 (USD Million)

TABLE 21    Assay & panels market size, by region, 2021 – 2027 (USD Million)

TABLE 22    Others market size, by region, 2016 – 2020 (USD Million)

TABLE 23    Others market size, by region, 2021 – 2027 (USD Million)

TABLE 24    Lung cancer market size, by region, 2016 – 2020 (USD Million)

TABLE 25    Lung cancer market size, by region, 2021 – 2027 (USD Million)

TABLE 26    Breast cancer market size, by region, 2016 – 2020 (USD Million)

TABLE 27    Breast cancer market size, by region, 2021 – 2027 (USD Million)

TABLE 28    Colorectal cancer market size, by region, 2016 – 2020 (USD Million)

TABLE 29    Colorectal cancer market size, by region, 2021 – 2027 (USD Million)

TABLE 30    Prostate cancer market size, by region, 2016 – 2020 (USD Million)

TABLE 31    Prostate cancer market size, by region, 2021 – 2027 (USD Million)

TABLE 32    Others market size, by region, 2016 – 2020 (USD Million)

TABLE 33    Others market size, by region, 2021 – 2027 (USD Million)

TABLE 34    North America liquid biopsy market, by country, 2016 – 2020 (USD Mn)

TABLE 35    North America liquid biopsy market, by country, 2021 – 2027 (USD Mn)

TABLE 36    North America liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 37    North America liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 38    North America liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 39    North America liquid biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 40    North America liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 41    North America liquid biopsy market, by application, 2021 – 2027 (USD Mn)

TABLE 42    U.S. liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 43    U.S. liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 44    U.S. liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 45    U.S. liquid biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 46    U.S. liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 47    U.S. liquid biopsy market, by application, 2021 – 2027 (USD Mn)

TABLE 48    Canada liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 49    Canada liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 50    Canada liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 51    Canada liquid biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 52    Canada liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 53    Canada liquid biopsy market, by application, 2021 – 2027 (USD Mn)

TABLE 54    Europe liquid biopsy market size, by country, 2016 – 2020 (USD Mn)

TABLE 55    Europe liquid biopsy market size, by country, 2021 – 2027 (USD Mn)

TABLE 56    Europe liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 57    Europe liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 58    Europe liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 59    Europe liquid biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 60    Europe liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 61    Europe liquid biopsy market, by application, 2021 – 2027 (USD Mn)

TABLE 62    Germany liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 63    Germany liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 64    Germany liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 65    Germany liquid biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 66    Germany liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 67    Germany liquid biopsy market, by application, 2021 – 2027 (USD Mn)

TABLE 68    UK liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 69    UK liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 70    UK liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 71    UK liquid biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 72    UK liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 73    UK liquid biopsy market, by application, 2021 – 2027 (USD Mn)

TABLE 74    France liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 75    France liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 76    France liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 77    France v biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 78    France Liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 79    France Liquid biopsy market, by application, 2021 – 2027 (USD Mn)

TABLE 80    Spain liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 81    Spain liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 82    Spain liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 83    Spain liquid biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 84    Spain liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 85    Spain liquid biopsy market, by application, 2021 – 2027 (USD Mn)

TABLE 86    Italy liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 87    Italy liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 88    Italy liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 89    Italy liquid biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 90    Italy liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 91    Italy liquid biopsy market, by application, 2021 – 2027 (USD Mn)

TABLE 92    Asia Pacific liquid biopsy market size, by country, 2016 – 2020 (USD Mn)

TABLE 93    Asia Pacific liquid biopsy market size, by country, 2021 – 2027 (USD Mn)

TABLE 94    Asia Pacific liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 95    Asia Pacific liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 96    Asia Pacific liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 97    Asia Pacific liquid biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 98    Asia Pacific liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 99    Asia Pacific liquid biopsy market, by application, 2021 – 2027 (USD Mn)

TABLE 100    China liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 101    China liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 102    China liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 103    China liquid biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 104    China liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 105    China liquid biopsy market, by application, 2021 – 2027 (USD Mn)

TABLE 106    India liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 107    India liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 108    India liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 109    India liquid biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 110    India liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 111    India liquid biopsy market, by application, 2021 – 2027 (USD Mn)

TABLE 112    Japan liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 113    Japan liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 114    Japan liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 115    Japan liquid biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 116    Japan liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 117    Japan liquid biopsy market, by application, 2021 – 2027 (USD Mn)

TABLE 118    Latin America liquid biopsy market size, by country, 2016 – 2020 (USD Mn)

TABLE 119    Latin America liquid biopsy market size, by country, 2021 – 2027 (USD Mn)

TABLE 120    Latin America liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 121    Latin America liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 122    Latin America liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 123    Latin America liquid biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 124    Latin America liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 125    Latin America liquid biopsy market, by application, 2021 – 2027 (USD Mn)

TABLE 126    Brazil liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 127    Brazil liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 128    Brazil liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 129    Brazil liquid biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 130    Brazil liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 131    Brazil liquid biopsy market, by application, 2021 – 2027 (USD Mn)

TABLE 132    Mexico liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 133    Mexico liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 134    Mexico liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 135    Mexico liquid biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 136    Mexico liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 137    Mexico liquid biopsy market, by application, 2021 – 2027 (USD Mn)

TABLE 138    MEA liquid biopsy market size, by country, 2016 – 2020 (USD Mn)

TABLE 139    MEA liquid biopsy market size, by country, 2021 – 2027 (USD Mn)

TABLE 140    MEA liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 141    MEA liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 142    MEA liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 143    MEA liquid biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 144    MEA liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 145    MEA liquid biopsy market, by application, 2021 – 2027 (USD Mn)

TABLE 146    South Africa liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 147    South Africa liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 148    South Africa liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 149    South Africa liquid biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 150    South Africa liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 151    South Africa liquid biopsy market, by application, 2021 – 2027 (USD Mn)

TABLE 152    Saudi Arabia liquid biopsy market, by biomarkers, 2016 – 2020 (USD Mn)

TABLE 153    Saudi Arabia liquid biopsy market, by biomarkers, 2021 – 2027 (USD Mn)

TABLE 154    Saudi Arabia liquid biopsy market, by product, 2016 – 2020 (USD Mn)

TABLE 155    Saudi Arabia liquid biopsy market, by product, 2021 – 2027 (USD Mn)

TABLE 156    Saudi Arabia liquid biopsy market, by application, 2016 – 2020 (USD Mn)

TABLE 157    Saudi Arabia liquid biopsy market, by application, 2021 – 2027 (USD Mn)

Charts & Figures

FIG 1    Liquid biopsy industry 360º synopsis, 2016 – 2027

FIG 2    Industry segmentation

FIG 3    Global liquid biopsy industry landscape, 2016 – 2027 (USD Million)

FIG 4    Growth potential analysis, by biomarkers

FIG 5    Growth potential analysis, by product

FIG 6    Growth potential analysis, by application

FIG 7    Porter’s analysis

FIG 8    PESTEL analysis

FIG 9    Key segment trends, by biomarkers

FIG 10

Market, By Biomarkers

  • Circulating Tumor Cells (CTC)
  • Circulating Tumor DNA (ctDNA)
  • Others

Market, By Product

  • Kits & Reagents
  • Assay & Reagents
  • Others

Market, By Application

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Others

F. Hoffmann-La Roche Ltd., BIOCEPT, Inc., QIAGEN, Myriad Genetics, Inc., Guardant Health, Inc., Illumina, Inc., Lucence health Inc., and EPIGENOMICS AG.

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF